Abstract
A move towards targeted screening of men at higher risk of prostate cancer offers the potential to improve outcomes. In this article, members of the Prostate Cancer UK Education Advisory Group outline ways in which primary care physicians can ensure that PSA testing is targeted at those who are most likely to benefit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
